| William R. Frist |
Director, 10%+ Owner |
$17B |
|
|
Apr 29, 2024 |
| Patricia F. Elcan |
10%+ Owner |
$16.9B |
|
|
Oct 30, 2024 |
| Thomas F. Frist III |
Director, 10%+ Owner |
$14.4B |
|
|
Apr 29, 2024 |
| Thomas F. Frist Jr |
10%+ Owner |
$8.68B |
|
|
May 2, 2022 |
| Samuel N. Hazen |
CEO, Director |
$430M |
|
|
Feb 13, 2025 |
| A. Bruce Moore Jr |
Group President - Service Line |
$88.2M |
|
|
Nov 11, 2022 |
| Bill B. Rutherford |
CFO and EVP |
$56.2M |
|
|
Feb 16, 2024 |
| Jon M. Foster |
EVP and COO |
$53.9M |
|
|
Feb 13, 2025 |
| Charles J. Hall |
Group President |
$47.6M |
|
|
Nov 11, 2022 |
| Erol R. Akdamar |
Group President |
$45M |
-$1.02M |
-2.23% |
Nov 12, 2024 |
| P. Martin Paslick |
SVP and CIO |
$34.9M |
|
|
Apr 12, 2023 |
| Mike A. Marks |
EVP and CFO |
$22.6M |
|
|
Feb 13, 2025 |
| Joseph A. Sowell III |
SVP; Chief Development Officer |
$20.4M |
|
|
Aug 5, 2024 |
| Jonathan B. Perlin |
Pres-Clinical Operations & CMO |
$18.7M |
|
|
Aug 2, 2021 |
| Phillip G. Billington |
SVP-Internal Audit Services |
$18.4M |
-$1.36M |
-6.89% |
Nov 12, 2024 |
| Christopher F. Wyatt |
SVP & Controller |
$13.2M |
-$1.44M |
-9.83% |
Feb 13, 2025 |
| Robert A. Waterman |
Former SVP & General Counsel |
$10.3M |
|
|
Dec 31, 2021 |
| Michael S. Cuffe |
EVP and Chief Clinical Officer |
$10.1M |
-$5.72M |
-36.1% |
Feb 13, 2025 |
| Timothy M. McManus |
Group President |
$9.81M |
|
|
Jul 31, 2024 |
| Robert J. Dennis |
Director |
$8.45M |
|
|
Apr 29, 2024 |
| Nancy Ann Deparle |
Director |
$6.85M |
|
|
Apr 29, 2024 |
| Kathryn A. Torres |
SVP-Payer Contracting & Align. |
$6.3M |
-$1.85M |
-22.7% |
Jul 25, 2024 |
| Richard A. Hammett |
Group President |
$5.53M |
|
|
Feb 16, 2024 |
| Jennifer Berres |
SVP & Chief Human Res. Officer |
$4.97M |
-$3.08M |
-38.2% |
Feb 13, 2025 |
| Wayne Riley |
Director |
$4.58M |
|
|
Apr 29, 2024 |
| Charles O. Holliday Jr |
Director |
$4.36M |
|
|
Apr 25, 2022 |
| J. William Morrow |
Former SVP - Fin. & Treasurer |
$3.99M |
|
|
Dec 31, 2021 |
| Sammie S. Mosier |
SVP & Chief Nurse Executive |
$3.58M |
|
|
Feb 13, 2025 |
| Michael W. Michelson |
Director |
$3.46M |
|
|
Apr 29, 2024 |
| Kathleen M. Whalen |
SVP & Chief Ethics Officer |
$3.38M |
-$3.33M |
-49.6% |
Nov 14, 2024 |
| Meg Crofton |
Director |
$2.09M |
|
|
Apr 29, 2024 |
| Michael R. McAlevey |
EVP & Chief Legal & Admin Off. |
$1.81M |
|
|
Feb 13, 2025 |
| Jeffrey E. Cohen |
SVP-Government Relations |
$1.62M |
-$516K |
-24.1% |
May 9, 2024 |
| Deborah M. Reiner |
SVP - Mktg. & Communications |
$1.26M |
-$1.19M |
-48.6% |
Jul 29, 2024 |
| Andrea B. Smith |
Director |
$1.19M |
|
|
Apr 29, 2024 |
| Hugh F. Johnston |
Director |
$872K |
|
|
Apr 29, 2024 |
| Chad J. Wasserman |
SVP and CIO |
$561K |
|
|
Mar 18, 2024 |
| Bank Of America Corp /De/ |
10%+ Owner |
$0 |
|
|
Jul 26, 2011 |
| Jane D. Englebright |
SVP and Chief Nursing Officer |
|
|
|
Nov 9, 2021 |